We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis' Zortress Patent Survives PTAB Challenge

Law360, New York (January 11, 2018, 4:38 PM EST) -- While certain claims in a Novartis AG patent for its immunosuppressant Zortress probably could have been found by other chemists based on existing knowledge, the chances were so small that the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.